Targeted proteomics identifies liquid-biopsy signatures for extracapsular prostate cancer

Targeted proteomics identifies liquid-biopsy signatures for extracapsular prostate cancer

Proteomic technologies are capable of identifying thousands of proteins in biological samples, but biomarker applications are lagging. Here the authors use Multiple Reaction Monitoring Mass Spectrometry to delineate peptide signatures that accurately distinguish between defined prostate cancer patie...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Yunee Kim, Jouhyun Jeon, Salvador Mejia, Cindy Q Yao, Vladimir Ignatchenko, Julius O Nyalwidhe, Anthony O Gramolini, Raymond S Lance, Dean A Troyer, Richard R Drake, Paul C Boutros, O. John Semmes, Thomas Kislinger
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2016
Materias:
Science
Q
Acceso en línea:https://doaj.org/article/1db668735dc049b6843a5ba098f31c1d
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:1db668735dc049b6843a5ba098f31c1d
record_format dspace
spelling oai:doaj.org-article:1db668735dc049b6843a5ba098f31c1d2021-12-02T14:38:56ZTargeted proteomics identifies liquid-biopsy signatures for extracapsular prostate cancer10.1038/ncomms119062041-1723https://doaj.org/article/1db668735dc049b6843a5ba098f31c1d2016-06-01T00:00:00Zhttps://doi.org/10.1038/ncomms11906https://doaj.org/toc/2041-1723Proteomic technologies are capable of identifying thousands of proteins in biological samples, but biomarker applications are lagging. Here the authors use Multiple Reaction Monitoring Mass Spectrometry to delineate peptide signatures that accurately distinguish between defined prostate cancer patient risk groups.Yunee KimJouhyun JeonSalvador MejiaCindy Q YaoVladimir IgnatchenkoJulius O NyalwidheAnthony O GramoliniRaymond S LanceDean A TroyerRichard R DrakePaul C BoutrosO. John SemmesThomas KislingerNature PortfolioarticleScienceQENNature Communications, Vol 7, Iss 1, Pp 1-10 (2016)
institution DOAJ
collection DOAJ
language EN
topic Science
Q
spellingShingle Science
Q
Yunee Kim
Jouhyun Jeon
Salvador Mejia
Cindy Q Yao
Vladimir Ignatchenko
Julius O Nyalwidhe
Anthony O Gramolini
Raymond S Lance
Dean A Troyer
Richard R Drake
Paul C Boutros
O. John Semmes
Thomas Kislinger
Targeted proteomics identifies liquid-biopsy signatures for extracapsular prostate cancer
description Proteomic technologies are capable of identifying thousands of proteins in biological samples, but biomarker applications are lagging. Here the authors use Multiple Reaction Monitoring Mass Spectrometry to delineate peptide signatures that accurately distinguish between defined prostate cancer patient risk groups.
format article
author Yunee Kim
Jouhyun Jeon
Salvador Mejia
Cindy Q Yao
Vladimir Ignatchenko
Julius O Nyalwidhe
Anthony O Gramolini
Raymond S Lance
Dean A Troyer
Richard R Drake
Paul C Boutros
O. John Semmes
Thomas Kislinger
author_facet Yunee Kim
Jouhyun Jeon
Salvador Mejia
Cindy Q Yao
Vladimir Ignatchenko
Julius O Nyalwidhe
Anthony O Gramolini
Raymond S Lance
Dean A Troyer
Richard R Drake
Paul C Boutros
O. John Semmes
Thomas Kislinger
author_sort Yunee Kim
title Targeted proteomics identifies liquid-biopsy signatures for extracapsular prostate cancer
title_short Targeted proteomics identifies liquid-biopsy signatures for extracapsular prostate cancer
title_full Targeted proteomics identifies liquid-biopsy signatures for extracapsular prostate cancer
title_fullStr Targeted proteomics identifies liquid-biopsy signatures for extracapsular prostate cancer
title_full_unstemmed Targeted proteomics identifies liquid-biopsy signatures for extracapsular prostate cancer
title_sort targeted proteomics identifies liquid-biopsy signatures for extracapsular prostate cancer
publisher Nature Portfolio
publishDate 2016
url https://doaj.org/article/1db668735dc049b6843a5ba098f31c1d
work_keys_str_mv AT yuneekim targetedproteomicsidentifiesliquidbiopsysignaturesforextracapsularprostatecancer
AT jouhyunjeon targetedproteomicsidentifiesliquidbiopsysignaturesforextracapsularprostatecancer
AT salvadormejia targetedproteomicsidentifiesliquidbiopsysignaturesforextracapsularprostatecancer
AT cindyqyao targetedproteomicsidentifiesliquidbiopsysignaturesforextracapsularprostatecancer
AT vladimirignatchenko targetedproteomicsidentifiesliquidbiopsysignaturesforextracapsularprostatecancer
AT juliusonyalwidhe targetedproteomicsidentifiesliquidbiopsysignaturesforextracapsularprostatecancer
AT anthonyogramolini targetedproteomicsidentifiesliquidbiopsysignaturesforextracapsularprostatecancer
AT raymondslance targetedproteomicsidentifiesliquidbiopsysignaturesforextracapsularprostatecancer
AT deanatroyer targetedproteomicsidentifiesliquidbiopsysignaturesforextracapsularprostatecancer
AT richardrdrake targetedproteomicsidentifiesliquidbiopsysignaturesforextracapsularprostatecancer
AT paulcboutros targetedproteomicsidentifiesliquidbiopsysignaturesforextracapsularprostatecancer
AT ojohnsemmes targetedproteomicsidentifiesliquidbiopsysignaturesforextracapsularprostatecancer
AT thomaskislinger targetedproteomicsidentifiesliquidbiopsysignaturesforextracapsularprostatecancer
_version_ 1718390758937985024

Ejemplares similares